Lai, S., Su, Y., Chi, C., Kuo, Y., Lee, K., Wu, Y., . . . Huang, Y. (2020). Correction to: DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation. J Exp Clin Cancer Res.
Dyfyniad Arddull ChicagoLai, Ssu-Chuan, et al. "Correction To: DNMT3b/OCT4 Expression Confers Sorafenib Resistance and Poor Prognosis of Hepatocellular Carcinoma Through IL-6/STAT3 Regulation." J Exp Clin Cancer Res 2020.
Dyfyniad MLALai, Ssu-Chuan, et al. "Correction To: DNMT3b/OCT4 Expression Confers Sorafenib Resistance and Poor Prognosis of Hepatocellular Carcinoma Through IL-6/STAT3 Regulation." J Exp Clin Cancer Res 2020.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.